|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.39 USD | -3.17% |
|
+1.76% | -19.47% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -3.35x | 1.66x | 0.01x | 1.12x | -6.58x | -5.77x | -.--% | 188.2Cr | |
| -4.22x | 15.31x | 0.42x | 2.35x | -3.15x | -3.06x | -.--% | 229.98Cr | |
| Average | -3.79x | 8.48x | 0.21x | 1.73x | -4.86x | -4.42x | 0% | 209.09Cr | |
| Weighted average by Cap. | -3.83x | 9.16x | 0.23x | 1.79x | -4.69x | -4.28x | 0% |
- Stock Market
- Equities
- SRPT Stock
- Sector Sarepta Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition